Skip to Main Content

Paper Details

Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma.
NPJ Genom Med
109
2017
T cell, T cell clones, cancer, melanoma, patients
Author NameAffiliation
Xingzhi SongThe University of Texas MD Anderson Cancer Center
Xingzhi SongThe University of Texas MD Anderson Cancer Center
Curtis GumbsThe University of Texas MD Anderson Cancer Center
Luigi NeziThe University of Texas MD Anderson Cancer Center
Lynda ChinThe University of Texas MD Anderson Cancer Center
Hussein A TawbiThe University of Texas MD Anderson Cancer Center
Michael A DaviesThe University of Texas MD Anderson Cancer Center
Michael A DaviesThe University of Texas MD Anderson Cancer Center
Jeffrey E GershenwaldThe University of Texas MD Anderson Cancer Center
Jeffrey E GershenwaldThe University of Texas MD Anderson Cancer Center
Jeffrey E GershenwaldThe University of Texas MD Anderson Cancer Center
Jeffrey E GershenwaldThe University of Texas MD Anderson Cancer Center
Jianhua HuThe University of Texas MD Anderson Cancer Center
Alexander J LazarThe University of Texas MD Anderson Cancer Center
Alexander J LazarThe University of Texas MD Anderson Cancer Center
Jianhua ZhangThe University of Texas MD Anderson Cancer Center
Jianhua ZhangThe University of Texas MD Anderson Cancer Center
Phillip A FutrealThe University of Texas MD Anderson Cancer Center
Jennifer A WargoThe University of Texas MD Anderson Cancer Center
Jennifer A WargoThe University of Texas MD Anderson Cancer Center
  • 1 - 20

Datasets

Release 1.2